BIOGEN INC. (BIIB) Operating income 2016–2021
BIOGEN INC. (BIIB) annual operating income history from SEC filings — each fiscal year as reported.
$2.8BFY2021 · since FY2016: $5.2B → $2.8B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2021 | $2.8B | -37.6% |
| FY2020 | $4.6B | -35.4% |
| FY2019 | $7.0B | +19.6% |
| FY2018 | $5.9B | +10.2% |
| FY2017 | $5.3B | +3.8% |
| FY2016 | $5.2B | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More BIIB financial trends
BIIB RevenueBIIB Net incomeBIIB Net marginBIIB Gross profitBIIB Gross marginBIIB Operating marginBIIB Operating cash flowBIIB Free cash flowBIIB Capital expendituresBIIB Return on equityBIIB Stock buybacksBIIB Dividends paidBIIB Total assetsBIIB Total liabilitiesBIIB Shareholders’ equityBIIB overview →